EW Quote, Trading Chart, Edwards Lifesciences Corporation
$83.10 Last:
-1.04% Change Percent:
$84.35 Open:
$83.10 Previous Close:
$84.35 High:
$82.71 Low:
2,508,972 Volume:
02/26/2021 04:56:36 pm Last Trade Date Time:
Quotes are delayed by 15 to 20 minutes.
Last Five Trading Days
| Stock Date | Open Price | Close Price | High | Low | Volume |
|---|---|---|---|---|---|
| 2021-02-26 | 84.35 | 83.1 | 84.35 | 82.71 | 2,508,972 |
| 2021-02-25 | 84.15 | 83.97 | 85.09 | 82.92 | 2,107,241 |
| 2021-02-24 | 85.28 | 84.45 | 86.08 | 84.44 | 1,926,329 |
| 2021-02-23 | 83.63 | 85.22 | 85.63 | 82.44 | 4,278,115 |
| 2021-02-22 | 83.81 | 83.34 | 84 | 82.76 | 3,099,034 |
| 2021-02-19 | 85.59 | 84.31 | 85.815 | 83.99 | 4,797,487 |
| 2021-02-18 | 84.44 | 85.24 | 86.1 | 83.26 | 2,293,681 |
| 2021-02-17 | 86.43 | 85.07 | 86.85 | 84.78 | 2,399,015 |
| 2021-02-16 | 88.2 | 86.98 | 88.2 | 86.13 | 2,273,542 |
| 2021-02-15 | 87.27 | 87.65 | 87.82 | 86.68 | 2,094,049 |
| 2021-02-12 | 87.27 | 87.65 | 87.82 | 86.68 | 2,092,147 |
| 2021-02-11 | 86.81 | 88.07 | 88.11 | 86.22 | 2,220,737 |
| 2021-02-10 | 86.01 | 86.39 | 86.74 | 85.62 | 2,688,258 |
| 2021-02-09 | 86.3 | 85.8 | 86.93 | 85.37 | 1,486,035 |
| 2021-02-08 | 85.15 | 86.08 | 86.3172 | 84.61 | 2,166,785 |
| 2021-02-05 | 85.96 | 85.1 | 86.19 | 85.02 | 1,969,482 |
| 2021-02-04 | 84.54 | 85.43 | 86.16 | 84.0234 | 2,441,316 |
| 2021-02-03 | 83.51 | 83.86 | 84.12 | 82.45 | 2,174,620 |
| 2021-02-02 | 82.22 | 83.97 | 84.72 | 82.01 | 2,514,979 |
| 2021-02-01 | 83.54 | 81.92 | 83.87 | 81.85 | 2,075,717 |
Edwards Lifesciences Corporation Company Name:
EW Stock Symbol:
NYSE Market:
Edwards Lifesciences Corporation Website:
News, Short Squeeze, Breakout and More Instantly...
-
How do we know what is going on behind the scenes of a company? According to Stock Traders Daily, a 20-year industry innovator, the best way to do this to to watch the price action in the stock. The Edwards Lifesciences (NYSE: EW) report below is a real world example. Included are...
-
Edwards RESILIA Tissue Aortic Valve Demonstrates Favorable Safety and Efficacy at Five Years PR Newswire AUSTIN, Texas , Jan. 31, 2021 /PRNewswire/ -- Edwards Lifesciences (NYSE: EW) today announced new data from the COMMENCE clinical trial that demonstrate Edwar...
-
Image source: The Motley Fool. Edwards Lifesciences Corp (NYSE: EW) Q4 2020 Earnings Call Jan 27, 2021 , 5:00 p.m. ET Operator Continue reading For further details see: Edwards Lifesciences Corp (EW) Q4 2020 Earnings Call Transcript